We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 861

U.S. Ban for Canadian Cannabis Workers?
  • Dickinson Wright
  • USA, Canada
  • October 17 2018

On October 17, 2018, Canada became the second country behind Uruguay to legalize adult recreational cannabis use, while the U.S. federal law on the

The DEA Affirms CBD Derived from “Marijuana” Is Federally Unlawful
  • Duane Morris LLP
  • USA
  • October 12 2018

The Controlled Substances Act defines “marijuana” as: all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin

The Long-Awaited Telemedicine Controlled Substance Prescribing Permit
  • Bryan Cave Leighton Paisner LLP
  • USA
  • October 11 2018

Last week, the United States Congress passed a 250-page bill addressing the opioid crisis entitled SUPPORT for Patients and Communities Act (the

First CBD Drug Receives FDA Approval
  • Knobbe Martens
  • USA
  • October 11 2018

The FDA recently announced its approval of GW Pharmaceutical’s Epidiolex drug, described as the first ever plant-derived cannabinoid medicine in the

Upon Further Review: The DEA Legalizes a Marijuana-Derived Drug
  • Shawe Rosenthal LLP
  • USA
  • October 10 2018

We’ve talked about this before. There is an ongoing tension between state laws decriminalizing or legalizing marijuana for medicinal purposes and

Alcohol Beverage Producers See Potential in Cannabis and Cannabis Derived Products
  • Greenspoon Marder LLP
  • USA
  • October 8 2018

Cannabis and cannabis derived products are a hot commodity and alcohol beverage producers, particularly brewers, see huge potential in the burgeoning

DEA Schedules a FDA-Approved CBD Drug
  • McDermott Will & Emery
  • USA
  • October 5 2018

As beverage manufacturers mull the creation and distribution of cannabidiol (CBD)-infused products, the US Drug Enforcement Administration’s (DEA)

Cannabis Advertising
  • Womble Bond Dickinson (US) LLP
  • USA
  • October 3 2018

On January 4th, Attorney General Jeff Sessions took a big step backward. He announced that the Department of Justice rescinded the " Cole Memo " and

Canada, Cannabis, and Crossing the Continent: Considerations for Canada-U.S. Companies, Business Travellers, and Investors
  • Dickinson Wright
  • USA, Canada
  • October 3 2018

Managing your company’s Canada-U.S. operations will become hazier following Canada’s October 2017 legalization of recreational cannabis. While the

Court Says Employer Cannot Refuse to Hire Based on Medical Marijuana Use
  • Akerman LLP
  • USA
  • October 2 2018

A Connecticut federal district court has found an employer liable for discrimination for failing to hire a medical marijuana user based on a drug test